Joint Formulary & PAD

Andexanet alfa - Anticoagulation reversal

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Infusion
Associated Icons :
Restrictions / Comments :
Important
Apixaban / rivaroxaban anticoagulant reversal. RESTRICTED to Haematologists only

PAD Profile

ChemicalSubstance :
Andexanet alfa
Indication :
Anticoagulation reversal
Group Name :
Keywords :
Factor Xa inhibitor, apixaban antidote, apixaban reversal, rivaroxaban antidote, rivaroxaban reversal, anticoagulant reversal
Brand Names Include :
Ondexxya
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
2

Other Indications

Below are listed other indications that Andexanet alfa is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Anticoagulation reversal.

Committee Recommendations (1)

The Surrey Heartlands Integrated Care System Area Prescribing Committee have agreed andexanet alfa, as an alternative treatment option, for reversing anticoagulation from apixaban or rivaroxaban,in adults with life threatening or uncontrolled bleeding from the gastrointestinal tract in line with NICE TA697

A RED traffic light status is agreed and the decision to treat should be made by a haematology consultant.